Almagate

Chemical compound
  • A02AD03 (WHO)
IdentifiersCAS Number
  • 66827-12-1
PubChem CID
  • 71749
ChemSpider
  • 64792 checkY
UNII
  • 568Z59H7ZJ
KEGG
  • D02821 checkY
CompTox Dashboard (EPA)
  • DTXSID30216935 Edit this at Wikidata
Chemical and physical dataFormulaAl2Mg6(OH)14(CO3)2 · 4 H2OMolar mass314.99 g/mol3D model (JSmol)
  • Interactive image
  • [Al+3].[Mg+2].[Mg+2].[Mg+2].[OH-].[OH-].[OH-].[O-]C([O-])=O.[OH-].[OH-].[OH-].[OH-].O.O
InChI
  • InChI=1S/CH2O3.Al.3Mg.9H2O/c2-1(3)4;;;;;;;;;;;;;/h(H2,2,3,4);;;;;9*1H2/q;+3;3*+2;;;;;;;;;/p-9 checkY
  • Key:MTEOMEWVDVPTNN-UHFFFAOYSA-E checkY
  (verify)

Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.[1][2]

Adverse effects

Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.[3]

References

  1. ^ Moragues J, Beneyto JE, Fábregas JL, Spickett RG (1984). "Characterization of a new crystalline synthetic gastric antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1346–9. PMID 6548918.
  2. ^ Beneyto JE, Fábregas JL, Moragues J, Spickett RG (1984). "Evaluation of a new antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1350–4. PMID 6439224.
  3. ^ Suau A, Dominguez Martin A, Ferrando Cucarella J, Juncosa Iglesias L, Muñoz Benitez J, Nieto Calvet M, et al. (1984). "Treatment of gastric pyrosis with almagate in patients with and without endoscopically demonstrable duodenal ulcer. A multicentre clinical trial" (Free full text). Arzneimittel-Forschung. 34 (10A): 1380–3. PMID 6548926.
Stub icon

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e